Paradox Immunotherapeutics

Biotechnology, Life Science, Pharmaceutical
Founded in 2019-01-01
Toronto, Ontario, Canada
For Profit

About Paradox Immunotherapeutics

Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases. It uses an immunotherapy drug design platform to design drugs that harness the body’s own immune system to clear lethal deposits from affected organs and reverse organ damage.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: None USD
  • Last Funding: None (Non-equity Assistance)
  • Funding Status:

Technology Stack

Paradox Immunotherapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Life Science, Pharmaceutical

Headquarters: Toronto, Ontario, Canada